Biomarkers in Psychiatric Disorders - A Perspective

Saeed Ahmed, Raheel Imtiaz Memon, Hema Venigalla, Hema Madhuri Mekala and Oubideh Ramadan

Department of Psychiatry, Nassau University Medical Center, USA
Puget Sound Psychiatric Center, USA
Texas Behavioral Health Clinic, USA
University of Missouri, USA
Hands Clinic of St Lucie County, USA

^*Correspondance to: Saeed Ahmed 

 PDF  Full Text Editorial | Open Access

Abstract:

Psychiatric disorders exert a considerable toll on society in various ways. Approximately 450 million people suffer from such conditions, which places mental disorders among the leading causes of ill-health and disability worldwide. The core definition of a psychiatric disorder is based on subjective symptoms/manifestations and/or behavioral criteria, which are always assessed clinically. Compared with some non-psychiatric disorders, our understanding of the pathophysiology of most psychiatric disorders is limited. The symptoms of different psychiatric disorders always overlap, and false-positive clinical diagnoses are possible. There are many instances where patients are under- or over- diagnosed, because there are no specific tests that can aid in diagnosis. As such, there is great interest in whether molecular biomarkers can assist in making clearer diagnostic decisions. To date several biomarkers are studied for various psychiatric disorders, however further research is needed to define a comprehensive set of biomarkers to improve confirmatory diagnosis, early interventions for treatment, and improve prognosis for particular disorders.

Keywords:

Cite the Article:

Ahmed S, Memon RI, Venigalla H, Mekala HM, Ramadan O. Biomarkers in Psychiatric Disorders � A Perspective. Ann Clin Case Rep. 2017; 2: 1289.